Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biocept Inc (BIOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3457
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocept Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biocept Enters into Research Agreement with University of Minnesota 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Biocept Enters into Partnership with Dana-Farber Cancer Institute 13
Equity Offering 14
Biocept Raise USD11.6 Million in Rights Offering of Units 14
Biocept Plans to Raise USD50 Million in Public Offering of Securities 16
Biocept Prices Public Offering of Shares for USD3.3 Million 17
Biocept Prices USD3.3 Million in Public Offering of Shares 19
Biocept Plans to Raise Funds through Private Placement of Shares 20
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 21
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept to Raise USD15 Million in Public Offering of Shares 25
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 26
Biocept Completes IPO For US$19 Million 28
Biocept Inc – Key Competitors 29
Biocept Inc – Key Employees 30
Biocept Inc – Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Aug 14, 2018: Biocept reports second quarter 2018 financial results 32
May 15, 2018: Biocept Announces First Quarter 2018 Financial Results 35
Mar 28, 2018: Biocept Reports 2017 Fourth Quarter and Full Year Financial Results 37
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 40
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 43
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 46
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 48
Corporate Communications 50
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept’s Clinical Advisory Board 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Biocept Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocept Enters into Research Agreement with University of Minnesota 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Biocept Enters into Partnership with Dana-Farber Cancer Institute 13
Biocept Raise USD11.6 Million in Rights Offering of Units 14
Biocept Plans to Raise USD50 Million in Public Offering of Securities 16
Biocept Prices Public Offering of Shares for USD3.3 Million 17
Biocept Prices USD3.3 Million in Public Offering of Shares 19
Biocept Plans to Raise Funds through Private Placement of Shares 20
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 21
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept to Raise USD15 Million in Public Offering of Shares 25
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 26
Biocept Completes IPO For US$19 Million 28
Biocept Inc, Key Competitors 29
Biocept Inc, Key Employees 30

List of Figures
Biocept Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endonovo Therapeutics Inc (ENDV):医療機器:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • BrainLAB AG:企業の戦略的SWOT分析
    BrainLAB AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Agfa HealthCare NV:医療機器:M&Aディール及び事業提携情報
    Summary Agfa HealthCare NV (Agfa HealthCare), a subsidiary of Agfa-Gevaert NV, is a healthcare information technology company, which provides eHealth and digital imaging solutions. It provides software for digital radiography, diagnostic imaging and healthcare IT solutions for hospitals and care cen …
  • LifeVantage Corp (LFVN):企業の財務・戦略的SWOT分析
    Summary LifeVantage Corp (LifeVantage) is a science-based nutraceutical company that manufactures and markets dietary supplements. The company provides products such as protandim, axio, physiq, truescience and canine health, among others. Its beauty products include cleansers, hand creams, micro lif …
  • Elizabeth Arden, Inc.:企業の戦略的SWOT分析
    Elizabeth Arden, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Millennium & Copthorne Hotels Plc:戦略・SWOT・企業財務分析
    Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Immunodiagnostic Systems Holdings plc (IDH):企業の財務・戦略的SWOT分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • FirstEnergy Corp:企業の発電所・SWOT分析2018
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aptinyx Inc (APTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptinyx Inc. (Aptinyx), formerly Enarex Inc, is a clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of neurological disorders. The company’s proprietary chemistry platform helps develop a pipeline of small-molecule modulators of N-methyl-D …
  • T-Mobile US Inc (TMUS):企業の財務・戦略的SWOT分析
    T-Mobile US Inc (TMUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Valeura Energy Inc (VLE):企業の財務・戦略的SWOT分析
    Valeura Energy Inc (VLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Marina Portoroz dd:企業の戦略・SWOT・財務分析
    Marina Portoroz dd - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Svenska Handelsbanken AB:企業のM&A・事業提携・投資動向
    Svenska Handelsbanken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Handelsbanken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Kinder Morgan, Inc.:企業の戦略・SWOT・財務分析
    Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zhejiang Jolly Pharmaceutical Co Ltd (300181):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Jolly Pharmaceutical Co Ltd (Zhejiang Jolly Pharma) is a producer and marketer of pharmaceutical products. The company offers products in the form of tablets, capsules, granules, injections, dry powders, and others. Its products include Wuling powder, pseudomonas moth powder, cordyc …
  • Power Assets Holdings Limited
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • RUAG Holding AG:企業の戦略・SWOT・財務情報
    RUAG Holding AG - Strategy, SWOT and Corporate Finance Report Summary RUAG Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Perry Ellis International Inc:企業のM&A・事業提携・投資動向
    Perry Ellis International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Perry Ellis International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆